Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN): A Pilot Randomized Controlled Study

NCT06489535 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT06489535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN): A Pilot Randomized Controlled Study
Lead sponsor
Boston Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2025
Completion date
May 11, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection, endocarditis, epidural abscess, opioid use disorder, osteomyelitis, septic arthritis